Latest news with #Blundy-controlled
Fashion Network
20-05-2025
- Business
- Fashion Network
Victoria's Secret adopts 'poison pill' after Australian billionaire's firm raises stake
Victoria's Secret adopted a shareholder rights plan on Tuesday, after Australian billionaire Brett Blundy's investment firm increased its stake in the lingerie maker. The 'poison pill' plan, known as a limited-duration shareholder rights plan, was adopted to "guard against tactics to gain control of the company without paying all shareholders an appropriate premium for that control," Board Chair Donna James said. Shares of Victoria's Secret were marginally higher at $22.87 in early trading. Under the plan, Victoria's Secret said it will issue one right per share on May 29, which would become active only if a shareholder acquires a 15% or more stake. Blundy-controlled BBRC International Private Limited has increased its stake in Victoria's Secret since March, the apparel maker said. As of April this year, the investment firm holds about 10.31 million shares, or about a 13% stake in the lingerie maker. BBRC bought Victoria's Secret shares for nearly three years without the required filings, which was in violation of U.S. antitrust rules, the specialty retailer said. The investment firm has now corrected its paperwork, which will enable it to acquire up to 49.99% of voting stock once a mandatory waiting period ends at 11:59 p.m. ET on May 21, Victoria's Secret added. Victoria's Secret's poison pill comes at a time when the lingerie maker has been grappling with tepid demand, as consumers avoid expensive purchases amid rising tariff uncertainty and fears of an economic recession. BBRC, which recently launched a new lingerie and beauty business, has a history of taking control of retail brands, Victoria's Secret said. Blundy's investment firm has also backed consumer companies such as shoe brand Bared Footwear and Oz Hair & Beauty.
Fashion Network
20-05-2025
- Business
- Fashion Network
Victoria's Secret adopts 'poison pill' after Australian billionaire's firm raises stake
Victoria's Secret adopted a shareholder rights plan on Tuesday, after Australian billionaire Brett Blundy's investment firm increased its stake in the lingerie maker. The 'poison pill' plan, known as a limited-duration shareholder rights plan, was adopted to "guard against tactics to gain control of the company without paying all shareholders an appropriate premium for that control," Board Chair Donna James said. Shares of Victoria's Secret were marginally higher at $22.87 in early trading. Under the plan, Victoria's Secret said it will issue one right per share on May 29, which would become active only if a shareholder acquires a 15% or more stake. Blundy-controlled BBRC International Private Limited has increased its stake in Victoria's Secret since March, the apparel maker said. As of April this year, the investment firm holds about 10.31 million shares, or about a 13% stake in the lingerie maker. BBRC bought Victoria's Secret shares for nearly three years without the required filings, which was in violation of U.S. antitrust rules, the specialty retailer said. The investment firm has now corrected its paperwork, which will enable it to acquire up to 49.99% of voting stock once a mandatory waiting period ends at 11:59 p.m. ET on May 21, Victoria's Secret added. Victoria's Secret's poison pill comes at a time when the lingerie maker has been grappling with tepid demand, as consumers avoid expensive purchases amid rising tariff uncertainty and fears of an economic recession. BBRC, which recently launched a new lingerie and beauty business, has a history of taking control of retail brands, Victoria's Secret said. Blundy's investment firm has also backed consumer companies such as shoe brand Bared Footwear and Oz Hair & Beauty.
Fashion Network
20-05-2025
- Business
- Fashion Network
Victoria's Secret adopts 'poison pill' after Australian billionaire's firm raises stake
Victoria's Secret adopted a shareholder rights plan on Tuesday, after Australian billionaire Brett Blundy's investment firm increased its stake in the lingerie maker. The 'poison pill' plan, known as a limited-duration shareholder rights plan, was adopted to "guard against tactics to gain control of the company without paying all shareholders an appropriate premium for that control," Board Chair Donna James said. Shares of Victoria's Secret were marginally higher at $22.87 in early trading. Under the plan, Victoria's Secret said it will issue one right per share on May 29, which would become active only if a shareholder acquires a 15% or more stake. Blundy-controlled BBRC International Private Limited has increased its stake in Victoria's Secret since March, the apparel maker said. As of April this year, the investment firm holds about 10.31 million shares, or about a 13% stake in the lingerie maker. BBRC bought Victoria's Secret shares for nearly three years without the required filings, which was in violation of U.S. antitrust rules, the specialty retailer said. The investment firm has now corrected its paperwork, which will enable it to acquire up to 49.99% of voting stock once a mandatory waiting period ends at 11:59 p.m. ET on May 21, Victoria's Secret added. Victoria's Secret's poison pill comes at a time when the lingerie maker has been grappling with tepid demand, as consumers avoid expensive purchases amid rising tariff uncertainty and fears of an economic recession. BBRC, which recently launched a new lingerie and beauty business, has a history of taking control of retail brands, Victoria's Secret said. Blundy's investment firm has also backed consumer companies such as shoe brand Bared Footwear and Oz Hair & Beauty.
Time of India
20-05-2025
- Business
- Time of India
Victoria's Secret share price rises as lingerie maker goes for 'poison pill' plan
Victoria's Secret share price went up higher at $22.87 in early trading on Tuesday. This comes even as Victoria's Secret adopted a shareholder rights plan on Tuesday, after Australian billionaire Brett Blundy's investment firm increased its stake in the lingerie maker. The 'poison pill' plan, known as a limited-duration shareholder rights plan, was adopted to "guard against tactics to gain control of the company without paying all shareholders an appropriate premium for that control," Board Chair Donna James said, Reuters reported. Under the plan, Victoria's Secret said it will issue one right per share on May 29, which would become active only if a shareholder acquires a 15 per cent or more stake. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like If You Eat Ginger Everyday for 1 Month This is What Happens Tips and Tricks Undo Blundy-controlled BBRC International Private Limited has increased its stake in Victoria's Secret since March, the apparel maker said. As of April this year, the investment firm holds about 10.31 million shares, or about a 13 per cent stake in the lingerie maker. BBRC bought Victoria's Secret shares for nearly three years without the required filings, which was in violation of U.S. antitrust rules, the specialty retailer said. Live Events The investment firm has now corrected its paperwork, which will enable it to acquire up to 49.99 per cent of voting stock once a mandatory waiting period ends at 11:59 p.m. (ET) on May 21, Victoria's Secret added. Victoria's Secret's poison pill comes at a time when the lingerie maker has been grappling with tepid demand, as consumers avoid expensive purchases amid rising tariff uncertainty and fears of an economic recession. BBRC, which recently launched a new lingerie and beauty business, has a history of taking control of retail brands, Victoria's Secret said. Blundy's investment firm has also backed consumer companies such as shoe brand Bared Footwear and Oz Hair & Beauty. BBRC did not immediately respond to Reuters' request for comment. FAQs Q1. What is Victoria's Secret? A1. Victoria's Secret is lingerie maker. Q2. What is 'poison pill'? A2. The 'poison pill' plan, known as a limited-duration shareholder rights plan, was adopted to "guard against tactics to gain control of the company without paying all shareholders an appropriate premium for that control," Board Chair Donna James said, Reuters reported.
Yahoo
20-05-2025
- Business
- Yahoo
Victoria's Secret adopts 'poison pill' after Australian billionaire's firm raises stake
(Reuters) - Victoria's Secret adopted a shareholder rights plan on Tuesday, after Australian billionaire Brett Blundy's investment firm increased its stake in the lingerie maker. The 'poison pill' plan, known as a limited-duration shareholder rights plan, was adopted to "guard against tactics to gain control of the company without paying all shareholders an appropriate premium for that control," Board Chair Donna James said. Shares of Victoria's Secret were marginally higher at $22.87 in early trading. Under the plan, Victoria's Secret said it will issue one right per share on May 29, which would become active only if a shareholder acquires a 15% or more stake. Blundy-controlled BBRC International Private Limited has increased its stake in Victoria's Secret since March, the apparel maker said. As of April this year, the investment firm holds about 10.31 million shares, or about a 13% stake in the lingerie maker. BBRC bought Victoria's Secret shares for nearly three years without the required filings, which was in violation of U.S. antitrust rules, the specialty retailer said. The investment firm has now corrected its paperwork, which will enable it to acquire up to 49.99% of voting stock once a mandatory waiting period ends at 11:59 p.m. ET on May 21, Victoria's Secret added. Victoria's Secret's poison pill comes at a time when the lingerie maker has been grappling with tepid demand, as consumers avoid expensive purchases amid rising tariff uncertainty and fears of an economic recession. BBRC, which recently launched a new lingerie and beauty business, has a history of taking control of retail brands, Victoria's Secret said. Blundy's investment firm has also backed consumer companies such as shoe brand Bared Footwear and Oz Hair & Beauty. BBRC did not immediately respond to Reuters' request for comment.
